Luye Pharma allocates $300m loan among nine
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings
Asia

Luye Pharma allocates $300m loan among nine

Pan Yue
January 25, 2019 02:30 AM
Pills_medicine_230px

Chinese drug developer Luye Pharma Group has closed a $300m loan after a five-month syndication.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Syndicated LoansUBSChinaHong Kong SARAsiaGreater ChinaNortheast AsiaLoans and High YieldAsia PacificLevFinLeveraged LoansEmerging Market LoansLevFin Leveraged LoansEmerging MarketsSRI
PY
Pan Yue
Loans reporter GlobalCapital Asia
Contact
Gift this article